1219 related articles for article (PubMed ID: 14615107)
1. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials.
Turnbull F;
Lancet; 2003 Nov; 362(9395):1527-35. PubMed ID: 14615107
[TBL] [Abstract][Full Text] [Related]
2. Effects of blood pressure lowering on outcome incidence in hypertension: 4. Effects of various classes of antihypertensive drugs--overview and meta-analyses.
Thomopoulos C; Parati G; Zanchetti A
J Hypertens; 2015 Feb; 33(2):195-211. PubMed ID: 25485720
[TBL] [Abstract][Full Text] [Related]
3. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration.
Neal B; MacMahon S; Chapman N;
Lancet; 2000 Dec; 356(9246):1955-64. PubMed ID: 11130523
[TBL] [Abstract][Full Text] [Related]
4. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.
Psaty BM; Lumley T; Furberg CD; Schellenbaum G; Pahor M; Alderman MH; Weiss NS
JAMA; 2003 May; 289(19):2534-44. PubMed ID: 12759325
[TBL] [Abstract][Full Text] [Related]
5. Effects of different blood-pressure-lowering regimens on major cardiac events.
Steffen HM; Toex U; Kolloch R
Lancet; 2004 Jan; 363(9405):331; author reply 331-2. PubMed ID: 14751718
[No Abstract] [Full Text] [Related]
6. Effects of blood pressure-lowering treatment on cardiovascular outcomes and mortality: 14 - effects of different classes of antihypertensive drugs in older and younger patients: overview and meta-analysis.
Thomopoulos C; Parati G; Zanchetti A
J Hypertens; 2018 Aug; 36(8):1637-1647. PubMed ID: 29847487
[TBL] [Abstract][Full Text] [Related]
7. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
[TBL] [Abstract][Full Text] [Related]
8. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B
Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721
[TBL] [Abstract][Full Text] [Related]
10. Effects of blood pressure-lowering treatment. 6. Prevention of heart failure and new-onset heart failure--meta-analyses of randomized trials.
Thomopoulos C; Parati G; Zanchetti A
J Hypertens; 2016 Mar; 34(3):373-84; discussion 384. PubMed ID: 26780184
[TBL] [Abstract][Full Text] [Related]
11. Goals of antihypertensive therapy.
McVeigh GE; Flack J; Grimm R
Drugs; 1995 Feb; 49(2):161-75. PubMed ID: 7729325
[TBL] [Abstract][Full Text] [Related]
12. Are there benefits to specific antihypertensive drug therapy?
Cushman WC
Am J Hypertens; 2003 Nov; 16(11 Pt 2):31S-35S. PubMed ID: 14625158
[TBL] [Abstract][Full Text] [Related]
13. Clinical efficacies of antihypertensive drugs.
Aursnes I; Tvete IF; Gåsemyr J; Natvig B
Scand Cardiovasc J; 2003 May; 37(2):72-9. PubMed ID: 12775305
[TBL] [Abstract][Full Text] [Related]
14. Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials.
Turnbull F; Neal B; Algert C; Chalmers J; Chapman N; Cutler J; Woodward M; MacMahon S;
Arch Intern Med; 2005 Jun; 165(12):1410-9. PubMed ID: 15983291
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological interventions for hypertension in children.
Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
[TBL] [Abstract][Full Text] [Related]
16. Effects of blood pressure-lowering on outcome incidence in hypertension: 5. Head-to-head comparisons of various classes of antihypertensive drugs - overview and meta-analyses.
Thomopoulos C; Parati G; Zanchetti A
J Hypertens; 2015 Jul; 33(7):1321-41. PubMed ID: 26039526
[TBL] [Abstract][Full Text] [Related]
17. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis.
Psaty BM; Smith NL; Siscovick DS; Koepsell TD; Weiss NS; Heckbert SR; Lemaitre RN; Wagner EH; Furberg CD
JAMA; 1997 Mar; 277(9):739-45. PubMed ID: 9042847
[TBL] [Abstract][Full Text] [Related]
18. Blood pressure-lowering drugs and secondary prevention of cardiovascular disease: systematic review and meta-analysis.
Xie W; Zheng F; Evangelou E; Liu O; Yang Z; Chan Q; Elliott P; Wu Y
J Hypertens; 2018 Jun; 36(6):1256-1265. PubMed ID: 29543625
[TBL] [Abstract][Full Text] [Related]
19. The World Health Organization--International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration: prospective collaborative overviews of major randomized trials of blood pressure-lowering treatments.
Neal B; MacMahon S
Curr Hypertens Rep; 1999 Aug; 1(4):346-56. PubMed ID: 10981089
[TBL] [Abstract][Full Text] [Related]
20. Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta-analysis.
Wu HY; Huang JW; Lin HJ; Liao WC; Peng YS; Hung KY; Wu KD; Tu YK; Chien KL
BMJ; 2013 Oct; 347():f6008. PubMed ID: 24157497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
